Highlights SkinBioTherapeutics plc

Equities

Market Closed - London S.E. Other stock markets 09:05:08 09/05/2024 pm IST			5-day change	1st Jan Change
8.85 ^GBX	0.00%		-4.32%	-41.97%

05/04	SkinBioTherapeutics Gets Bond Conversion Notice from Macquarie	MT
22/03	SkinBioTherapeutics half-year revenue jumps on UK-based sales	AN

SkinBioTherapeutics Gets Bond Conversion Notice from Macquarie	05/04	MT
SkinBioTherapeutics half-year revenue jumps on UK-based sales	22/03	AN
SkinBioTherapeutics plc Provides Earnings Guidance for the Year Ending June 30, 2024	22/03	CI
SkinBioTherapeutics plc Reports Earnings Results for the Half Year Ended December 31, 2023	22/03	CI
SkinBioTherapeutics Launches Project for Development of Wound Healing Technology	18/03	MT
SkinBioTherapeutics announces research into wound healing bacterium	18/03	AN
SkinBioTherapeutics plc Initiates a Research and Development Project with the University of Manchester	18/03	CI
Avacta plans fundraise to fund clinical development	29/02	AN
Windward extends LSEG pact; Vinanz eyes DTC trading	27/02	AN
SkinBioTherapeutics plc Announces Positive Interim Data from Consumer Participant Study for Acne	27/02	CI
SkinBio's Dermatonics launches Once Heel Balm in Asia, ME and Africa	20/02	AN
SkinBioTherapeutics Unit Plans Roll Out of Dry Foot Skin Treatment Balm	20/02	MT
SkinBioTherapeutics up after successful year for Dermatonics	06/02	AN
SkinBioTherapeutics completes Dermatonics purchase	26/01	AN
SkinBioTherapeutics Finalizes Dermatonics Purchase; Shares Fall	26/01	MT
SkinBioTherapeutics plc acquired Dermatonics Ltd.	26/01	CI
SkinBioTherapeutics buys Dermatonics; in talks for 2nd deal	25/01	AN
SkinBioTherapeutics Obtains GBP5 Million Convertible Bond Loan	25/01	MT
SkinBioTherapeutics to Buy Skin Cream Brand Dermatonics	25/01	MT
SkinBioTherapeutics plc agreed to acquire Dermatonics Ltd for £1.68 million.	25/01	CI

No results for this search